|
151 |
Guidelines for the Scheme Strengthening of Pharmaceuticals Industry (SPI)- Notification of the modifications of the few clauses in the GLs - regarding |
|
|
152 |
Filling up the post of Director (Finance) in Bengal Chemicals & Pharmaceuticals Ltd.(BCPL) through PESB selection mode.- regarding |
|
|
153 |
O.M. dated 02.05.2022 to Central Procurement Agencies to exercise due diligence on the claims of the local manufacturers while proceeding for the procurement |
|
|
154 |
Seeking comments/views/ suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg |
|
|
155 |
Guidelines on Pharmaceutical Innovation & Entrepreneurship |
|
|
156 |
FAQs on the Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme 'Strengthening of Pharmaceuticals Industry' (SPI) |
|
|
157 |
Extension of timeline to submit proposal: Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme Strengthening of Pharmaceuticals Industry (SPI) |
|
|
158 |
Approval accorded to the States under the scheme 'Promotion of Medical Devices Park' |
|
|
159 |
Awards to the leading Pharma and Medical Devices Industry playersIndia Pharma 2022 & India Medical Devices 2022-Extension of Date for invitation of Applications -reg |
|
|
160 |
Annual Report 2021-22 |
|
|
161 |
Invitation of Applications for the posts of Director of NIPER- Ahmedabad and NIPER-Raebareli |
|
|
162 |
Invitation of Applications under the PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) - extension till 30.04.2022 |
|
|
163 |
Notice: PPDS scheme for FY 21-22 - Selection of agencies for conducting studies (Long Term and Short Term) - reg. |
|
|
164 |
Portal for India Pharma and India Medical Device Awards |
|
|
165 |
Timeline Extension for filling applications under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) upto 31.03.2022 |
|
|
166 |
Guidelines for the Scheme for Strengthening of Pharmaceuticals Industry (SPI) |
|
|
167 |
Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022. |
|
|
168 |
Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022 |
|
|
169 |
Public Notice dated 28.02.2022 :Inviting details of local manufacturers of specific Drugs -reg. |
|
|
170 |
List of approved applicants under PLI Scheme for Bulk Drug (Dated :20-01-2021) |
|
|
171 |
Public Notice dated 01.02.2022: Relaxation on Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs) 2017 for procurement of Medical Devices - reg. |
|
|
172 |
Hiring of Technical Consultant for Pharmaceuticals and Medical Devices. |
|
|
173 |
Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country |
|
|
174 |
List of approved applicants under PLI Scheme for Medical Devices |
|
|
175 |
Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021 |
|
|
176 |
Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021 |
|
|
177 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals |
|
|
178 |
List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India |
|
|
179 |
Inviting details of local manufacturers of specific medical devices/equipments |
|
|
180 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
181 |
Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals |
|
|
182 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
183 |
FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof |
|
|
184 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
185 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
186 |
Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
187 |
Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India |
|
|
188 |
Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India |
|
|
189 |
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
190 |
R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
191 |
Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC). |
|
|
192 |
Corrigendum under PLI scheme for Pharmaceuticals |
|
|
193 |
Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract. |
|
|
194 |
Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India. |
|
|
195 |
Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices |
|
|
196 |
Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013. |
|
|
197 |
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals |
|
|
198 |
Engagement of 04 Consultant(Non-tech, SO level) in the Department of Pharmaceuticals- reg |
|
|
199 |
Revised Notice- Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country |
|
|
200 |
Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals |
|
औषध विभाग
Department of
